首页> 外文期刊>China National Journal of New Gastroenterology >Clinical significance of CD44v mRNA detection in peripheral blood of patients with hepatocellular carcinoma by RCR
【24h】

Clinical significance of CD44v mRNA detection in peripheral blood of patients with hepatocellular carcinoma by RCR

机译:RCR检测肝细胞癌患者外周血CD44v mRNA的临床意义

获取原文
获取原文并翻译 | 示例
           

摘要

AIM To study the clinical significance of detecting the CD44v mRNA expression in the blood of patients with hepatocellular carcinoma (HCC). METHODS The expression of CD44v mRAN was detected in blood with RT and diploid PCR and the clinical significance was discussed based on the result of pathological examination and follow-up. RESULTS CD44v mRNA was detected in the blood of 10/15 patients, with a positive rate of 66.67%. In 13 patients who responded to the follow-up, CD44v mRNA expression was positive in 9 cases and negative in 4 cases. Recurrence rate in the patients with positive expression of CD44v mRNA was higher than in those with negative CD44v mRNA expression, and the clinical pathological indexes were also higher in the former than in the latter. CONCLUSION Detection of the CD44v mRNA in blood of the patients with HCC can be used as an adjuvant means for differential diagnosis, prediction and monitoring of the recurrence of HCC.
机译:目的探讨检测肝细胞癌(HCC)患者血液中CD44v mRNA表达的临床意义。方法采用RT和二倍体PCR检测血液中CD44v mRAN的表达,结合病理检查结果和随访结果探讨其临床意义。结果在10/15患者的血液中检测到CD44v mRNA,阳性率为66.67%。在对随访有反应的13例患者中,CD44v mRNA表达阳性9例,阴性4例。 CD44v mRNA表达阳性的患者的复发率高于CD44v mRNA表达阴性的患者的复发率,前者的临床病理指标也高于后者。结论检测肝癌患者血液中的CD44v mRNA可作为鉴别诊断,预测和监测肝癌复发的辅助手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号